Difamilast
- Generic Name
- Difamilast
- Drug Type
- Small Molecule
- Chemical Formula
- C23H24F2N2O5
- CAS Number
- 937782-05-3
- Unique Ingredient Identifier
- T3U32GLJ0F
- Background
Difamilast is under investigation in clinical trial NCT01702181 (A Safety Study to Evaluate the Use and Effectiveness of a Topical Ointment to Treat Adults With Atopic Dermatitis).
This Study is to Assess the Efficacy of Difamilast Ointment in Mild to Moderate Atopic Dermatitis(AD)
- First Posted Date
- 2022-11-08
- Last Posted Date
- 2024-08-15
- Lead Sponsor
- Acrotech Biopharma Inc.
- Target Recruit Count
- 153
- Registration Number
- NCT05608343
- Locations
- 🇺🇸
Nona Pediatrics, Orlando, Florida, United States
🇺🇸Tory Sullivan, MD PA, North Miami Beach, Florida, United States
🇺🇸Avant Research Associates, LLC, Crowley, Louisiana, United States
A Open-label Study to Assess the Long-term Safety of Difamilast Ointment 1% in Mild to Moderate Atopic Dermatitis
- First Posted Date
- 2022-10-07
- Last Posted Date
- 2024-08-09
- Lead Sponsor
- Acrotech Biopharma Inc.
- Target Recruit Count
- 542
- Registration Number
- NCT05571943
- Locations
- 🇺🇸
Qualmedica Research, LLC, Bowling Green, Kentucky, United States
🇺🇸Antelope Valley Clinical Trials, Lancaster, California, United States
🇺🇸Dermatology Research Associates, Los Angeles, California, United States
A Long-term Trial of OPA-15406 in Infants With Atopic Dermatitis
- First Posted Date
- 2022-05-13
- Last Posted Date
- 2025-03-30
- Lead Sponsor
- Otsuka Pharmaceutical Co., Ltd.
- Target Recruit Count
- 41
- Registration Number
- NCT05372653
- Locations
- 🇯🇵
Sotobo Children's Clinic, Isumi, Japan
Phase 2 Study of OPA-15406 Ointment in Pediatric Patients With Atopic Dermatitis
- First Posted Date
- 2017-01-12
- Last Posted Date
- 2020-07-23
- Lead Sponsor
- Otsuka Pharmaceutical Co., Ltd.
- Target Recruit Count
- 73
- Registration Number
- NCT03018691
Study of OPA-15406 Ointment in Patients With Atopic Dermatitis
- First Posted Date
- 2016-09-26
- Last Posted Date
- 2020-07-23
- Lead Sponsor
- Otsuka Pharmaceutical Co., Ltd.
- Target Recruit Count
- 200
- Registration Number
- NCT02914548
A Study to Evaluate the Effectiveness and Safety of Topical OPA-15406 Ointment to Treat Participants With Atopic Dermatitis
- First Posted Date
- 2014-02-21
- Last Posted Date
- 2021-11-23
- Target Recruit Count
- 121
- Registration Number
- NCT02068352
A Safety Study to Evaluate the Use and Effectiveness of a Topical Ointment to Treat Adults With Atopic Dermatitis
Phase 1
Completed
- Conditions
- Atopic Dermatitis
- Interventions
- First Posted Date
- 2012-10-05
- Last Posted Date
- 2014-01-17
- Target Recruit Count
- 92
- Registration Number
- NCT01702181
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath